Senzar Asset Management as of Sept. 30, 2016
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 35 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sanofi-Aventis SA (SNY) | 14.2 | $55M | 1.4M | 38.19 | |
Eli Lilly & Co. (LLY) | 9.0 | $35M | 435k | 80.26 | |
Anthem (ELV) | 7.1 | $28M | 219k | 125.31 | |
Shire | 6.9 | $27M | 138k | 193.86 | |
Express Scripts Holding | 5.4 | $21M | 298k | 70.53 | |
Aetna | 3.7 | $14M | 124k | 115.45 | |
Endologix | 3.6 | $14M | 1.1M | 12.80 | |
Enanta Pharmaceuticals (ENTA) | 3.5 | $14M | 507k | 26.61 | |
Allergan | 3.5 | $14M | 59k | 230.31 | |
MiMedx (MDXG) | 3.4 | $13M | 1.5M | 8.58 | |
Valeant Pharmaceuticals Int | 3.1 | $12M | 489k | 24.55 | |
Momenta Pharmaceuticals | 2.9 | $11M | 962k | 11.69 | |
Retrophin | 2.7 | $11M | 471k | 22.38 | |
Molina Healthcare (MOH) | 2.7 | $11M | 180k | 58.32 | |
Mylan Nv | 2.7 | $10M | 274k | 38.12 | |
Alder Biopharmaceuticals | 2.5 | $9.7M | 297k | 32.77 | |
Corium Intl | 2.3 | $9.0M | 1.6M | 5.63 | |
Insmed (INSM) | 2.2 | $8.6M | 593k | 14.52 | |
Tesaro | 2.2 | $8.5M | 84k | 100.24 | |
Adeptus Health Inc-class A | 1.8 | $7.0M | 164k | 43.05 | |
Halozyme Therapeutics (HALO) | 1.7 | $6.7M | 551k | 12.08 | |
Concert Pharmaceuticals I equity | 1.5 | $5.8M | 572k | 10.11 | |
Foamix Pharmaceuticals | 1.2 | $4.8M | 523k | 9.26 | |
Array BioPharma | 1.1 | $4.2M | 627k | 6.75 | |
Acorda Therapeutics | 1.0 | $4.0M | 192k | 20.88 | |
Inotek Pharmaceuticals | 1.0 | $3.9M | 414k | 9.48 | |
Select Medical Holdings Corporation (SEM) | 1.0 | $3.7M | 276k | 13.50 | |
Aerie Pharmaceuticals | 0.9 | $3.5M | 92k | 37.74 | |
Tandem Diabetes Care | 0.9 | $3.5M | 455k | 7.66 | |
Aviragen Therapeutics | 0.9 | $3.4M | 1.8M | 1.92 | |
Rigel Pharmaceuticals | 0.9 | $3.3M | 907k | 3.67 | |
Neuroderm Ltd F | 0.8 | $3.2M | 171k | 18.49 | |
Arena Pharmaceuticals | 0.7 | $2.9M | 1.6M | 1.75 | |
Zogenix | 0.4 | $1.6M | 138k | 11.43 | |
Paratek Pharmaceuticals | 0.4 | $1.5M | 117k | 13.01 |